Table 6 Determination of variance inflation factor (VIF)
GLM 1 | GLM 2 | ||||
|---|---|---|---|---|---|
Variable | VIF | 1/VIF | Variable | VIF | 1/VIF |
Adverse events (0 = absent, 1 = present) | 1.470 | 0.682 | Adverse events (count predictor) | 2.000 | 0.500 |
Hospitalization (0 = no, 1 = yes) | 1.550 | 0.644 | Hospitalization (0 = No, 1 = Yes) | 1.320 | 0.760 |
Age (years) | 1.470 | 0.680 | Age (years) | 1.470 | 0.679 |
Deaths | 1.440 | 0.696 | Deaths | 2.050 | 0.488 |
Time to get ALL remission (days) | 1.280 | 0.782 | Time to get ALL remission (days) | 1.310 | 0.761 |
Risk of neoplastic relapse (0 = standard, 1 = high) | 1.210 | 0.827 | Risk of neoplastic relapse (0 = standard, 1 = high) | 1.210 | 0.827 |
Sex (0 = male, 1 = female) | 1.100 | 0.906 | Sex (0 = male, 1 = female) | 1.140 | 0.876 |
Mean VIF | 1.360 | Mean VIF | 1.500 |